Hydrogen Peroxide Oral Rinse Recalled for Manufacturing Deviations
Den-Mat Holdings recalls Hydrogen Peroxide Oral Rinse products nationwide due to manufacturing deviations that may result in products not conforming to labeled specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries and a manufacturing compliance issue that is precautionary in nature. The hazard is theoretical—products may not meet specifications—rather than a known safety incident.
Plain-English summary
Den-Mat Holdings, LLC is recalling Hydrogen Peroxide Oral Rinse in three sizes (16 fl. oz., 64 fl. oz., and 128 fl. oz. bottles) with Fresh Mint Flavor and alcohol-free formula, manufactured in Lompoc, California.
The recall is being issued due to Current Good Manufacturing Practice (CGMP) deviations discovered during manufacturing. These deviations may result in products not conforming to their labeled specifications.
Approximately 10,103 units were distributed nationwide in the United States. Multiple lot numbers are affected, with expiration dates spanning from February 2024 through December 2025. Consumers who have purchased affected products should stop using them and consult their healthcare provider or dentist if they have any questions.
The recalled product
- Product
- Hydrogen Peroxide Oral Rinse, Significantly Reduces Bacteria, Fresh Mint Flavor, Alcohol Free, a)16 fl. oz. (473 mL) bottle, NDC 59883-202-16, UPC 3 59883 00009 7); b) 64 fl. oz. (1.89 L) bottle, NDC 59883-202-64; c) 128 fl. oz. (1 gal) 3.78L bottle, NDC 59883-202-28, UPC 3…
- Manufacturer
- Den-Mat Holdings, LLC
- Category
- Drug — Oral Rinse
- Hazard
- Affected units
- 10,103
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 2214500032
- 2216700041
- 2301900118
- 2312600002
- 2204800002
- Exp. 02/05/2024
- 2306100034
- 2322000078
- 2322200021 02/22/2024
- 2318000026
- Exp 02/24/2024
- 2323000070
- 2324400005
- 2323300016
- Exp 08/29/2025
- 2324800079
- Exp 08/30/2025
- 2325800008
- Exp 09/18/2025
- 2328600011
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Den-Mat Holdings, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Den-Mat Holdings, LLC
See all →- HighOralProCare Medicated Lip Treatment Recalled for Manufacturing Specification Deviations
FDA (Drugs) · 2024-02-07
Same hazard · non conformance
See all →- ModerateFord Recalls 2012-2013 C-Max and Focus Electric for Missing Door Chime
NHTSA · 2013-10-17
Other drug recalls
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- ModerateHouston Rx LLC Recalls Sermorelin Vials Due to Process Control Issues
FDA (Drugs) · 2026-10-21
- SevereZydus Recalls Hydrocortisone Sodium Succinate Injection for Impurity Failures
FDA (Drugs) · 2026-10-21
Similar recalls
- ModerateHydrogen Peroxide Recalled Due to Improper Storage Conditions
FDA (Drugs) · 2022-08-31
- ModeratePrecision Dose Recalls Chlorhexidine Gluconate Oral Rinse Due to cGMP Deviations
FDA (Drugs) · 2021-01-20
- SevereHi-Tech Pharmacal Recalls HydrOXYzine Hydrochloride Oral Solution Due to Impurity
FDA (Drugs) · 2014-11-05
- High
- SevereAkorn Recalls PerioRx Oral Rinse Due to Unknown Impurity
FDA (Drugs) · 2016-06-01
- HighXttrium Recalls Chlorhexidine Gluconate Oral Rinse Due to CGMP Deviations
FDA (Drugs) · 2017-07-12